These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12544092)

  • 1. Gene expression profiling of melanocytic lesions.
    Seykora JT; Jih D; Elenitsas R; Horng WH; Elder DE
    Am J Dermatopathol; 2003 Feb; 25(1):6-11. PubMed ID: 12544092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
    Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
    Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
    Nai G; Marques M
    Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE; Bosenberg M
    Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
    Bröcker EB; Magiera H; Herlyn M
    J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
    Gerami P; Alsobrook JP; Palmer TJ; Robin HS
    J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
    Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
    Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
    Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions.
    Ratushny V; Kraft S; Moschella SL; Duncan LM; Lawrence DP; Tsao H
    JAMA Dermatol; 2016 Sep; 152(9):1021-4. PubMed ID: 27192392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.
    Collins KA; White WL
    Am J Dermatopathol; 1995 Oct; 17(5):429-38. PubMed ID: 8599446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometry of melanocytic skin lesions--verifications or vexations? A review of a group experience.
    Williams RA
    Pathologica; 1998 Apr; 90(2):183-5. PubMed ID: 9619064
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
    Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
    Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.